This project introduces a novel, commercially promising ocular implant for the treatment of degenerative retinal diseases, initially targeting age-related macular degeneration (AMD) as a leading cause of vision loss. Current treatments for AMD require frequent intravitreal injections due to the rapid clearance of therapeutics from the eye. This frequent need for injections can cause significant […]
Read More